Skip to main content

and
  1. No Access

    Article

    Concurrent chemoradiotherapy combined with nimotuzumab in stage III–IVa nasopharyngeal carcinoma: a retrospective analysis

    The efficacy and safety of nimotuzumab (NTZ) added to concurrent chemoradiotherapy (CCRT) were investigated in patients with stage III–IVa nasopharyngeal carcinoma (NPC).

    Zhuochen Cai, Dongni Chen, Wenze Qiu in Journal of Cancer Research and Clinical On… (2023)

  2. No Access

    Article

    Platinum-based concurrent chemotherapy remains the optimal regimen for nasopharyngeal carcinoma: a large institutional-based cohort study from an endemic area

    To retrospectively investigate the optimal regimen of concurrent chemotherapy for nasopharyngeal carcinoma (NPC) by comparing clinical outcomes of patients who received platinum-based and non-platinum-based co...

    Yahui Yu, Hu Liang, **ng Lv, Liangru Ke in Journal of Cancer Research and Clinical On… (2018)